Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -6.97%1.28B | -10.00%866.97M | -2.32%400.12M | 5.66%1.85B | 11.36%1.38B | 26.01%963.25M | 5.04%409.63M | -6.82%1.75B | -16.94%1.24B | -24.72%764.45M |
| Operating revenue | -6.97%1.28B | -10.00%866.97M | -2.32%400.12M | 5.66%1.85B | 11.36%1.38B | 26.01%963.25M | 5.04%409.63M | -6.82%1.75B | -16.94%1.24B | -24.72%764.45M |
| Other operating revenue | ---- | -9.28%12.97M | ---- | 52.73%31.18M | ---- | 11.76%14.29M | ---- | -29.85%20.42M | ---- | -28.15%12.79M |
| Total operating cost | -6.17%1.5B | -6.94%993.93M | 0.10%466.58M | -4.21%2.25B | 0.02%1.6B | 8.79%1.07B | -14.08%466.11M | 8.84%2.35B | -0.19%1.6B | -3.40%981.79M |
| Operating cost | -5.83%1.43B | -6.37%948.05M | -1.43%436.25M | -2.84%2.1B | 1.90%1.51B | 10.99%1.01B | -14.46%442.57M | 7.40%2.16B | 0.44%1.49B | -4.24%912.26M |
| Operating tax surcharges | -91.38%1.19M | -143.33%-3.6M | 18.32%4.87M | 451.06%18.48M | 2.77%13.78M | -9.52%8.31M | -4.32%4.11M | -81.32%3.35M | 2.17%13.41M | 4.42%9.19M |
| Operating expense | 30.96%3.57M | -74.65%2.32M | -72.53%1.04M | -23.94%4.55M | -77.00%2.73M | 7.67%9.15M | -11.80%3.79M | -64.39%5.98M | -7.01%11.86M | 12.16%8.49M |
| Administration expense | -2.94%55.27M | 20.57%39.45M | 32.16%19.41M | -38.67%107.19M | -36.01%56.94M | -39.77%32.71M | -19.55%14.68M | 47.19%174.77M | -15.14%88.98M | 1.40%54.31M |
| Financial expense | 54.99%12.27M | 89.69%6.97M | 540.83%4.52M | 680.19%12.98M | 396.62%7.91M | 249.27%3.67M | 141.41%705.32K | 80.77%-2.24M | 72.17%-2.67M | 60.88%-2.46M |
| -Interest expense (Financial expense) | 56.03%12.36M | 91.64%7.01M | 651.74%4.55M | 2,653.71%12.12M | --7.92M | --3.66M | --604.84K | --440.12K | ---- | ---- |
| -Interest Income (Financial expense) | -30.89%-100.26K | -1.97%-47.45K | -8.26%-29.06K | 95.85%-116.14K | 97.19%-76.6K | 98.14%-46.53K | 98.43%-26.84K | 76.28%-2.8M | 72.06%-2.72M | 61.08%-2.51M |
| Research and development | -52.98%1.09M | -56.25%755.5K | 96.85%496.03K | 36.94%4.98M | 201,713.83%2.31M | --1.73M | --251.98K | 91.70%3.64M | --1.15K | ---- |
| Credit Impairment Loss | 331.24%188.93K | 238.06%149.09K | -43.82%8.39K | -9,743.08%-2.16M | 8.69%-81.7K | 3.36%-107.99K | --14.94K | 117.92%22.37K | -241.74%-89.48K | -326.76%-111.74K |
| Asset Impairment Loss | 5.47%-29.5M | -70.14%-26.3M | -35.29%-18.98M | -116.53%-96.38M | 75.29%-31.21M | 87.76%-15.46M | -32.94%-14.03M | 75.95%-44.51M | -195.72%-126.27M | -195.72%-126.27M |
| Other net revenue | 9.29%-25.8M | -76.07%-23.94M | -31.56%-17.82M | -1,601.99%-93.86M | 62.54%-28.45M | 82.38%-13.6M | -1,732.76%-13.54M | 103.45%6.25M | -91.77%-75.94M | -88.17%-77.18M |
| Fair value change income | --98.95K | -102.63%-17.55K | -82.45%25.35K | --17.55K | ---- | --666.2K | --144.48K | ---- | ---- | ---- |
| Invest income | -86.91%103.15K | 243.46%103.48K | ---- | 687.72%787.72K | --787.75K | ---72.13K | ---301.97 | --100K | ---- | ---- |
| Asset deal income | ---- | ---- | ---- | -101.35%-653.79K | -101.35%-653.79K | ---- | ---- | --48.44M | --48.44M | --48.44M |
| Other revenue | 22.12%3.3M | 54.60%2.12M | 243.61%1.13M | 105.71%4.53M | 36.22%2.71M | 78.87%1.37M | -35.71%329.98K | -45.03%2.2M | -36.51%1.99M | -55.14%766.74K |
| Operating profit | 2.10%-244.32M | -27.41%-150.9M | -20.35%-84.28M | 16.38%-498.43M | 42.92%-249.55M | 59.78%-118.44M | 54.32%-70.03M | -28.24%-596.1M | -187.75%-437.19M | -602.27%-294.52M |
| Add:Non operating Income | 35.64%3.67M | 25.97%2.08M | 954.07%2.05M | -33.33%4.93M | -28.28%2.71M | -49.89%1.65M | 977.77%194.9K | 68.27%7.39M | -64.88%3.78M | 200.34%3.3M |
| Less:Non operating expense | 141.67%55.93K | 32.63%30.69K | 32.71%13.45K | -13.68%17.19M | -99.87%23.14K | --23.14K | --10.13K | 600.25%19.91M | 637.92%18.06M | ---- |
| Total profit | 2.50%-240.7M | -27.43%-148.85M | -17.75%-82.24M | 16.09%-510.69M | 45.32%-246.87M | 59.89%-116.81M | 54.43%-69.84M | -31.37%-608.62M | -214.34%-451.47M | -602.42%-291.22M |
| Less:Income tax cost | -39.14%6.73M | -0.28%6.73M | ---- | -113.74%-8.12M | -56.08%11.05M | -0.84%6.74M | ---- | 179.49%59.15M | 1,342.61%25.16M | 385.00%6.8M |
| Net profit | 4.07%-247.43M | -25.92%-155.58M | -17.75%-82.24M | 24.74%-502.56M | 45.89%-257.92M | 58.54%-123.56M | 54.43%-69.84M | -71.72%-667.77M | -236.60%-476.64M | -662.73%-298.02M |
| Net profit from continuing operation | 4.07%-247.43M | -25.92%-155.58M | -17.75%-82.24M | 24.74%-502.56M | 45.89%-257.92M | 58.54%-123.56M | 54.43%-69.84M | -71.72%-667.77M | -236.60%-476.64M | -662.73%-298.02M |
| Net profit of parent company owners | 4.07%-247.43M | -25.92%-155.58M | -17.75%-82.24M | 24.74%-502.56M | 45.89%-257.92M | 58.54%-123.56M | 54.43%-69.84M | -71.72%-667.77M | -236.60%-476.64M | -662.73%-298.02M |
| Earning per share | ||||||||||
| Basic earning per share | 7.63%-0.785 | -24.39%-0.51 | -17.39%-0.27 | 24.66%-1.65 | 45.87%-0.8498 | 58.16%-0.41 | 54.00%-0.23 | -71.09%-2.19 | -234.04%-1.57 | -653.85%-0.98 |
| Diluted earning per share | 7.63%-0.785 | -24.39%-0.51 | -17.39%-0.27 | 24.66%-1.65 | 45.87%-0.8498 | 58.16%-0.41 | 54.00%-0.23 | -71.09%-2.19 | -234.04%-1.57 | -653.85%-0.98 |
| Other composite income | ||||||||||
| Total composite income | 4.07%-247.43M | -25.92%-155.58M | -17.75%-82.24M | 24.74%-502.56M | 45.89%-257.92M | 58.54%-123.56M | 54.43%-69.84M | -71.72%-667.77M | -236.60%-476.64M | -662.73%-298.02M |
| Total composite income of parent company owners | 4.07%-247.43M | -25.92%-155.58M | -17.75%-82.24M | 24.74%-502.56M | 45.89%-257.92M | 58.54%-123.56M | 54.43%-69.84M | -71.72%-667.77M | -236.60%-476.64M | -662.73%-298.02M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.